| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |